An International Phase 3 Randomized Trial of Autologous Dendritic Cell Immunotherapy (AGS-003) Plus Standard Treatment of Advanced Renal Cell Carcinoma (ADAPT)
An Open-label, Multicenter Phase II Study to Examine the Efficacy and Safety of Everolimus as Second-line Therapy in the Treatment of Patients With Metastatic Renal Cell Carcinoma
A Phase Ib/II Trial of ALT-801 in Combination with Cisplatin and Gemcitabine in Muscle Invasive or Metastatic Urothelial Cancer
St. Luke's Maintains its Thought-Leadership Position by Piloting Connectivity to PA's Health Information Exchange (HIE)
New Cholesterol Guidelines: What Should You Know?
St. Luke's University Health Network Holds 'Coats for Kids' Program for 21st Year